A granulocytosis associated with rufinamide: A case report

Andrès, 2008, Idiosyncratic drug-induced agranulocytosis or acute neutropenia, Curr Opin Hematol, 15, 15, 10.1097/MOH.0b013e3282f15fb9 Flanagan, 2008, Haematological toxicity of drugs used in psychiatry, Hum Psychopharmacol, 23, 27, 10.1002/hup.917 Stübner, 2004, Blood dyscrasias induced by psychotropic drugs, Pharmacopsychiatry, 37, S70, 10.1055/s-2004-815513 Hsieh, 2013, Efficacy and safety of rufinamide in pediatric epilepsy, Ther Adv Neurol Disord, 6, 189, 10.1177/1756285613481083 Wheless, 2009, Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies, J Child Neurol, 24, 1520, 10.1177/0883073809350508 Thome-Souza, 2014, Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience, Epilepsia, 55, 1235, 10.1111/epi.12689 Ural, 2005, Leukopenia and thrombocytopenia possibly associated with lamotrigine use in a patient, Epileptic Disord, 7, 33 Tesfa, 2009, Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management, Am J Hematol, 84, 428, 10.1002/ajh.21433 Lu, 2008, Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin, Drug Metab Dispos, 36, 1624, 10.1124/dmd.107.019554